2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors
Portfolio Pulse from
Teladoc Health and Novavax, once high-performing pandemic stocks, have seen significant declines since 2021, making them potential opportunities for contrarian investors.
December 05, 2024 | 10:45 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novavax, a vaccine maker, has experienced a significant stock price decline since 2021, making it a potential target for contrarian investors.
Novavax was a key player in the vaccine market during the pandemic, but its stock has underperformed since 2021. This decline may present an opportunity for contrarian investors who believe the stock is undervalued.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Teladoc Health, a telemedicine company, has seen its stock price decline significantly since 2021, presenting a potential opportunity for contrarian investors.
Teladoc Health was a high-performing stock during the pandemic due to increased demand for telemedicine. However, its stock has declined significantly since 2021, suggesting it may be undervalued and a potential opportunity for contrarian investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80